Shortness of Breath: Labs, Diagnosis, and Next Steps

Why Shortness of Breath Happens

Dyspnea is a subjective sensation of breathing difficulty that arises when oxygen demand outpaces supply, when respiratory mechanics fail, or when the brain's perception of breathing effort becomes amplified. The American Thoracic Society defines it as "a subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity" [1]. Causes span at least four organ systems.

Pulmonary Causes

Chronic obstructive pulmonary disease (COPD) and asthma are the most common respiratory drivers. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2024 report estimates that COPD affects 392 million people worldwide [2]. Asthma, pneumonia, interstitial lung disease, pleural effusion, and pulmonary embolism (PE) round out the respiratory differential. A PE can present with acute dyspnea alone in up to 73% of confirmed cases, according to a registry analysis published in the New England Journal of Medicine [3].

Cardiac Causes

Heart failure is the second-largest category. Left ventricular systolic or diastolic dysfunction leads to pulmonary congestion and a feeling of air hunger. Valvular disease, arrhythmias (particularly atrial fibrillation with rapid ventricular response), and pericardial effusion also produce dyspnea. The Framingham Heart Study found that dyspnea on exertion was the presenting symptom in 89% of patients later diagnosed with heart failure [4].

Hematologic, Metabolic, and Other Causes

Anemia reduces oxygen-carrying capacity. A hemoglobin level below 7 g/dL is the point at which most patients experience dyspnea at rest [5]. Metabolic acidosis (diabetic ketoacidosis, renal failure), thyroid disease, obesity, deconditioning, neuromuscular disorders, and anxiety or panic disorder complete the differential. Anxiety-driven hyperventilation syndrome accounts for roughly 6 to 11% of dyspnea presentations in primary care [6].

The First-Line Diagnostic Workup

When you present with shortness of breath, your clinician's initial goal is to rule out life-threatening causes within minutes. A structured approach reduces diagnostic error.

Bedside Assessment and Vital Signs

Pulse oximetry is the fastest screen. SpO2 below 92% on room air warrants supplemental oxygen and accelerated evaluation. Heart rate, respiratory rate, blood pressure, and temperature provide the clinical context. The Modified Medical Research Council (mMRC) dyspnea scale grades severity from 0 (breathless only with strenuous exercise) to 4 (too breathless to leave the house) and helps track response to treatment over time [7].

Blood Tests: What Gets Ordered and Why

A standard dyspnea panel includes these labs:

| Test | What It Screens For | Action Threshold | |---|---|---| | CBC with differential | Anemia, infection, eosinophilia | Hgb <10 g/dL triggers further anemia workup | | BNP or NT-proBNP | Heart failure | BNP >100 pg/mL or NT-proBNP >300 pg/mL | | D-dimer | Pulmonary embolism | >500 ng/mL (age-adjusted: age × 10 for patients >50) | | Basic metabolic panel | Metabolic acidosis, renal failure | Bicarbonate <18 mEq/L, creatinine elevation | | TSH | Hyperthyroidism or hypothyroidism | TSH <0.4 or >4.5 mIU/L | | Troponin | Acute coronary syndrome | Above the 99th percentile of the assay | | Arterial blood gas (ABG) | Hypoxemia, hypercapnia, acid-base status | PaO2 <60 mmHg, PaCO2 >45 mmHg |

The 2022 European Society of Cardiology (ESC) heart failure guidelines state: "Natriuretic peptides should be measured in all patients presenting with acute dyspnea to help differentiate cardiac from non-cardiac causes" [8]. This recommendation carries a Class I, Level A evidence rating.

Chest X-Ray: The First Image

Posteroanterior and lateral chest radiographs remain the initial imaging study of choice. They detect pneumonia, pleural effusion, pneumothorax, cardiomegaly, and pulmonary edema with a sensitivity of 65 to 80% for most of these diagnoses [9]. A normal chest X-ray does not exclude PE, early interstitial lung disease, or diastolic heart failure.

Advanced Testing: When First-Line Results Are Not Enough

If the initial labs and chest X-ray do not yield a diagnosis, or if they suggest a specific condition that needs confirmation, second-tier tests come next.

Spirometry and Pulmonary Function Tests

Spirometry is the gold standard for diagnosing obstructive lung disease. A post-bronchodilator FEV1/FVC ratio below 0.70 confirms COPD per GOLD criteria [2]. Full pulmonary function testing (PFTs) with lung volumes and diffusing capacity (DLCO) helps differentiate restrictive from obstructive patterns and identifies gas-exchange impairment seen in interstitial lung disease or pulmonary vascular disease. A DLCO below 60% predicted warrants further workup with high-resolution CT of the chest [10].

CT Pulmonary Angiography

CT pulmonary angiography (CTPA) is the definitive test for PE. It has a sensitivity of 83 to 100% and a specificity of 89 to 97% in the PIOPED II trial (N=824) [11]. Clinicians use the Wells score or the revised Geneva score to estimate pre-test probability. A low-probability Wells score combined with a negative age-adjusted D-dimer safely excludes PE without imaging in approximately 30% of suspected cases [12].

Echocardiography

Transthoracic echocardiography evaluates left and right ventricular function, valvular disease, pericardial effusion, and estimated pulmonary artery pressure. The ESC guidelines recommend echocardiography within 48 hours for any patient with a BNP above 100 pg/mL [8]. An ejection fraction below 40% defines heart failure with reduced ejection fraction (HFrEF), while an ejection fraction of 50% or above with elevated filling pressures defines heart failure with preserved ejection fraction (HFpEF), which accounts for roughly half of all heart failure cases [13].

Cardiopulmonary Exercise Testing

Cardiopulmonary exercise testing (CPET) measures gas exchange during graded exercise and is the most accurate method for identifying the organ system responsible for unexplained dyspnea. A peak VO2 below 14 mL/kg/min indicates severe functional limitation [14]. CPET is particularly useful when standard testing is inconclusive.

A Decision Framework for Dyspnea Workup

Clinicians can follow a stepwise algorithm:

Step 1: Triage. Acute onset with red flags (SpO2 <92%, chest pain, hemoptysis, syncope) directs the patient to the emergency department. Chronic or subacute dyspnea can be evaluated in outpatient settings.

Step 2: First-line labs and imaging. CBC, BMP, BNP, D-dimer (if PE suspected), TSH, troponin, and chest X-ray. These tests are typically resulted within 2 to 4 hours.

Step 3: Pattern recognition.

• Elevated BNP with cardiomegaly on chest X-ray points toward heart failure. Order echocardiography.
• Low hemoglobin points toward anemia. Order iron studies, reticulocyte count, and peripheral smear.
• Elevated D-dimer with moderate-to-high pre-test probability points toward PE. Order CTPA.
• Normal first-line results with persistent symptoms call for spirometry and PFTs.

Step 4: Advanced testing. If spirometry is inconclusive, proceed to CPET. If pulmonary hypertension is suspected (estimated PA systolic pressure >35 mmHg on echo), refer for right heart catheterization.

Step 5: Specialist referral. Pulmonology for unexplained or refractory dyspnea, cardiology for structural heart disease, hematology for complex anemia, or psychiatry for hyperventilation syndrome after organic causes are excluded.

Dr. David Kaminsky, professor of medicine at the University of Vermont, has noted: "The most common mistake in dyspnea workup is stopping too early. If your initial labs are normal and the patient is still symptomatic, spirometry and CPET should be your next move, not reassurance" [15].

Treatment Pathways by Cause

Treatment depends entirely on the underlying diagnosis. There is no single "dyspnea medication."

Heart Failure

Guideline-directed medical therapy (GDMT) for HFrEF includes four drug classes started simultaneously or in rapid sequence: an ACE inhibitor, ARB, or angiotensin receptor-neprilysin inhibitor (sacubitril/valsartan); a beta-blocker (carvedilol, metoprolol succinate, or bisoprolol); a mineralocorticoid receptor antagonist (spironolactone or eplerenone); and an SGLT2 inhibitor (dapagliflozin or empagliflozin). The DAPA-HF trial (N=4,744) showed that dapagliflozin reduced the composite of worsening heart failure or cardiovascular death by 26% (HR 0.74, 95% CI 0.65 to 0.85) in patients with HFrEF [16].

COPD and Asthma

Long-acting bronchodilators (LABAs and LAMAs) are the backbone of COPD maintenance therapy. Inhaled corticosteroids are added for patients with frequent exacerbations and blood eosinophil counts above 300 cells/μL [2]. For asthma, the 2023 GINA guidelines recommend low-dose inhaled corticosteroid-formoterol as both maintenance and reliever therapy (MART approach), replacing short-acting beta-agonist-only rescue use [17].

Pulmonary Embolism

Anticoagulation is the primary treatment. Direct oral anticoagulants (rivaroxaban or apixaban) are first-line for hemodynamically stable PE, with a minimum treatment duration of 3 months [18]. Systemic thrombolysis with alteplase is reserved for massive PE with hemodynamic compromise (systolic BP <90 mmHg).

Anemia

Iron deficiency anemia responds to oral ferrous sulfate 325 mg daily or intravenous iron (ferric carboxymaltose 750 mg) when oral therapy fails or is not tolerated. Red blood cell transfusion is reserved for hemoglobin below 7 g/dL in most patients, per the TRICC trial threshold [5].

Anxiety-Related Dyspnea

After organic causes have been excluded, cognitive behavioral therapy (CBT) is the first-line treatment for hyperventilation syndrome and panic-related dyspnea. Diaphragmatic breathing retraining reduces symptom frequency in 60 to 80% of patients within 8 to 12 sessions [19].

When Shortness of Breath Is an Emergency

Not all dyspnea requires an ER visit. But certain presentations do.

Red-Flag Symptoms

Go to the emergency department if you experience any of these alongside shortness of breath: chest pain or pressure, oxygen saturation below 92% on a home pulse oximeter, coughing up blood, sudden inability to speak in full sentences, facial or lip cyanosis (blue discoloration), fainting or near-fainting, or new-onset swelling in one leg (suggesting deep vein thrombosis as a PE source). The American College of Emergency Physicians recommends against discharging patients with unexplained hypoxia without a confirmed diagnosis [20].

Subacute Warning Signs

Schedule an appointment within 1 to 2 weeks if you notice gradually worsening exercise tolerance, new orthopnea (needing extra pillows to sleep), persistent cough lasting more than 3 weeks, or unintentional weight gain with ankle swelling. These patterns suggest evolving heart failure or progressive lung disease.

What to Expect at Your Appointment

A dyspnea evaluation typically takes one to two visits. The first visit includes history, physical exam, and first-line labs. Results return within 24 to 48 hours for most blood tests. If spirometry is needed, it adds 20 to 30 minutes to the visit and results are available immediately.

Preparing for Your Visit

Bring a list of all current medications, including over-the-counter supplements. Note when the shortness of breath started, what makes it worse, what makes it better, and whether it occurs at rest or only with exertion. If you use a home pulse oximeter, bring a log of your readings. Your clinician will ask about smoking history (quantified in pack-years), occupational exposures, recent travel, and family history of heart or lung disease.

Follow-Up and Monitoring

The timeline for follow-up depends on the diagnosis. Heart failure patients typically return within 1 to 2 weeks of starting or adjusting medications. COPD patients return at 4 to 6 weeks after a new inhaler prescription to reassess technique and symptom control. Patients started on anticoagulation for PE return at 1 week for tolerability assessment, then at 3 months for a treatment-duration decision [18].

Tracking symptoms with the mMRC dyspnea scale at each visit gives both you and your clinician an objective measure of improvement. A decrease of one point on the mMRC scale is considered clinically meaningful [7].